Examples of 'non-haematological' in a sentence
Meaning of "non-haematological"
non-haematological (adjective) - Referring to something that is not related to blood or blood disorders. This term is often used in medical contexts to differentiate conditions or tests that do not involve blood components
How to use "non-haematological" in a sentence
Basic
Advanced
non-haematological
Other non-haematological toxicities excluding metabolic events.
There were no signs of cumulative haematological or non-haematological toxicity.
Non-haematological adverse reactions are generally mild to moderate in severity.
Dose reduction for patients experiencing non-haematological toxicities.
After improvement of non-haematological adverse reactions, the dose of Nexavar may be increased.
The information may be used in diagnosis of a solid tumour or a non-haematological cell tumour.
Other non-haematological or haematological adverse reaction of ≥ grade 3.
Reoccurrence of any haematological or non-haematological adverse reactions as specified above.
Palifermin should therefore not be given to patients with known or suspected non-haematological malignancies.
Grade ≥ 3 non-haematological toxicities considered to be related to bortezomib.
It did not induce a proliferative response in non-haematological tumor cell lines in vitro.
Non-haematological adverse reactions.
This drug is a potent antineoplastic agent with potentially significant haematological and non-haematological adverse reactions.
Other non-haematological toxicities.
Dose adjustment for adverse reactions Non-haematological adverse reactions.
See also
The most frequent non-haematological drug-related adverse events were rash, pruritus, nausea, fatigue and headache.
Dose reduction for patients experiencing non-haematological toxicities Infectious events.
Grade ≥ 3 non-haematological toxicities considered to be related to VELCADE.
Thrombocyte count CTC non-haematological toxicity.
Non-haematological toxicities should have resolved to Grade 1 or baseline.
Tables 3 and 4 show the dose modification guidelines for haematological and non-haematological toxicities, respectively.
If a severe non-haematological adverse reaction develops with SPRYCEL ® use, treatment.
Evoltra is a potent antineoplastic agent with potentially significant haematological and non-haematological adverse reactions see section 4.8.
Dose modifications for non-haematological toxicities at any time during treatment Non-haematological toxicity Dose modification ( s ).
Ivozall is a potent antineoplastic agent with potentially significant haematological and non-haematological adverse reactions ( see section 4.8 ).
CTC non-haematological Toxicity except for alopecia, nausea, vomiting.
Dose reduction guidelines for haematological and non-haematological toxicities are provided in Tables 1 and 2.
CTC non-haematological toxicity.
Table 3 - Recommended dose modifications for Lonsurf in case of haematological and non-haematological adverse reactions.
XALKORI dose modification - non-haematological toxicities CTCAEa Grade.
A method according to claim 27 or 28 wherein said premalignant lesions occur in non-haematological malignancies.
Grade ≥ 3 non-haematological toxicity ( if persisting despite medical treatment ).
XALKORI dose modification - non-haematological toxicities.
Only mild non-haematological toxicities consisting of nausea g 1, mucositis g 1, asthenia g 1 were reported.
Nausea ≥ grade 3 despite anti-emetic treatment Other non-haematological or haematological adverse reaction of ≥ grade 3.
Common toxicity criteria ( CTC ) non-haematological toxicity ≤ Grade 1 except for alopecia, nausea.
Common toxicity criteria ( CTC ) non-haematological toxicity ≤ Grade 1 except for alopecia, nausea and vomiting.
Other Grade 3 or 4 non-haematological toxicities.
